Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
General Information
Version
5/11/2015
Revision date
2015-05-11
Product name
Glucagon for Injection
Product name
Glucagon for Injection
Identification on the label/Trade name
Glucagon for Injection | Manufacturer Fresenius Kabi USA LLC
Manufacturer Name
Fire Hazard
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
Section 2
SECTION 2: Hazards identification
Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation, Ingestion, Eye contact, Skin Absorption, Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Skin May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Adverse reactions from therapeutic doses include: nausea and vomiting may occur after use of glucagon. Hypersensitivity reactions, abdominal pain, hypotension, tachycardia, and hypokalemia have also been reported. A person may exhibit a rapid heart rate and nausea and vomiting. May increase blood pressure. Target Organs Liver, gastrointestinal system and the cardiovascular system Aggravation of Pre-Existing Individuals who have insulinoma and/or pheochromocytoma may experience an allergic reaction to Conditions Glucagon.
